15-deoxy-Δ12,14-prostaglandin J2-glycerol ester, a putative metabolite of 2-arachidonyl glycerol, activates peroxisome proliferator activated receptor γ

Molecular Pharmacology

Volumn 80, Issue 1, 2011, Pages 201-209

  Raman, Priyadarshini ^a   Kaplan, Barbara L F ^a   Thompson, Jerry T ^b   Vanden Heuvel, John P ^b   Kaminski, Norbert E ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; 2 ARACHIDONOYLGLYCEROL; 2 CHLORO 5 NITRO N (4 PYRIDYL)BENZAMIDE; CIGLITAZONE; CYCLOOXYGENASE 2; INTERLEUKIN 2; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ROSIGLITAZONE; TRANSCRIPTION FACTOR NFAT; 15 DEOXY DELTA(12,14) PROSTAGLANDIN J2; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J2; DRUG DERIVATIVE; PROSTAGLANDIN D2;

ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG MECHANISM; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN SECRETION; T LYMPHOCYTE ACTIVATION; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; METABOLISM;

ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INTERLEUKIN-2; JURKAT CELLS; PPAR GAMMA; PROSTAGLANDIN D2;

EID: 79959292610     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.110.070441     Document Type: Article

References (40)

1. Altmann R, Hausmann M, Spöttl T, Gruber M, Bull AW, Menzel K, Vogl D, Herfarth H, Schölmerich J, Falk W, et al. (2007) 13-Oxo-ODE is an endogenous ligand for PPARgamma in human colonic epithelial cells. Biochem Pharmacol 74:612-622. (Pubitemid 47042013)
2. Angeli V, Hammad H, Staels B, Capron M, Lambrecht BN, and Trottein F (2003) Peroxisome proliferator-activated receptor gamma inhibits the migration of dendritic cells: consequences for the immune response. J Immunol 170:5295-5301. (Pubitemid 36554764)
3. Berdyshev EV (2005) Endocannabinoids in Inflammation and Immune Response. CRC Press, Boca Raton, FL.
4. Berdyshev EV, Schmid PC, Krebsbach RJ, and Schmid HH (2001) Activation of PAF receptors results in enhanced synthesis of 2-arachidonoylglycerol (2-AG) in immune cells. FASEB J 15:2171-2178. (Pubitemid 32927934)
5. Bull AW, Steffensen KR, Leers J, and Rafter JJ (2003) Activation of PPAR gamma in colon tumor cell lines by oxidized metabolites of linoleic acid, endogenous ligands for PPAR gamma. Carcinogenesis 24:1717-1722. (Pubitemid 37419906)
6. Carrier EJ, Kearn CS, Barkmeier AJ, Breese NM, Yang W, Nithipatikom K, Pfister SL, Campbell WB, and Hillard CJ (2004) Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism. Mol Pharmacol 65:999-1007. (Pubitemid 38420506)
7. Clark RB, Bishop-Bailey D, Estrada-Hernandez T, Hla T, Puddington L, and Padula SJ (2000) The nuclear receptor PPAR gamma and immunoregulation: PPAR gamma mediates inhibition of helper T cell responses. J Immunol 164:1364-1371. (Pubitemid 30067250)
8. Clipstone NA and Crabtree GR (1992) Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature 357:695-697.
9. Cunard R, Eto Y, Muljadi JT, Glass CK, Kelly CJ, and Ricote M (2004) Repression of IFN-gamma expression by peroxisome proliferator-activated receptor gamma. J Immunol 172:7530-7536. (Pubitemid 38747616)
10. Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM, and Evans RM (1995) 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 83:803-812. (Pubitemid 3006324)
11. Fukui N, Honda K, Ito E, and Ishikawa K (2009) Peroxisome proliferator-activated receptor gamma negatively regulates allergic rhinitis in mice. Allergol Int 58:247-253.
12. Glass CK and Rosenfeld MG (2000) The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev 14:121-141. (Pubitemid 30070977)
13. Guri AJ, Mohapatra SK, Horne WT 2nd, Hontecillas R, and Bassaganya-Riera J (2010) The role of T cell PPAR gamma in mice with experimental inflammatory bowel disease. BMC Gastroenterol 10:60.
14. Han S, Inoue H, Flowers LC, and Sidell N (2003) Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells. Clin Cancer Res 9:4627-4635. (Pubitemid 37248424)
15. Inoue H, Tanabe T, and Umesono K (2000) Feedback control of cyclooxygenase-2 expression through PPARgamma. J Biol Chem 275:28028-28032.
16. Kaplan BL, Rockwell CE, and Kaminski NE (2003) Evidence for cannabinoid receptor-dependent and -independent mechanisms of action in leukocytes. J Pharmacol Exp Ther 306:1077-1085. (Pubitemid 37025316)
17. Kliewer SA, Sundseth SS, Jones SA, Brown PJ, Wisely GB, Koble CS, Devchand P, Wahli W, Willson TM, Lenhard JM, et al. (1997) Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc Natl Acad Sci USA 94:4318-4323. (Pubitemid 27194239)
18. Klotz L, Burgdorf S, Dani I, Saijo K, Flossdorf J, Hucke S, Alferink J, Nowak N, Novak N, Beyer M, et al. (2009) The nuclear receptor PPAR gamma selectively inhibits Th17 differentiation in a T cell-intrinsic fashion and suppresses CNS autoimmunity. J Exp Med 206:2079-2089.
19. Kozak KR, Crews BC, Morrow JD, Wang LH, Ma YH, Weinander R, Jakobsson PJ, and Marnett LJ (2002) Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides. J Biol Chem 277:44877-44885.
20. Lee M, Yang KH, and Kaminski NE (1995) Effects of putative cannabinoid receptor ligands, anandamide and 2-arachidonyl-glycerol, on immune function in B6C3F1 mouse splenocytes. J Pharmacol Exp Ther 275:529-536. (Pubitemid 26025542)
21. Lehmann JM, Lenhard JM, Oliver BB, Ringold GM, and Kliewer SA (1997) Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs. J Biol Chem 272: 3406-3410.
22. Li MY, Deng H, Zhao JM, Dai D, and Tan XY (2003) PPARgamma pathway activation results in apoptosis and COX-2 inhibition in HepG2 cells. World J Gastroenterol 9:1220-1226. (Pubitemid 36805656)
23. Macian F (2005) NFAT proteins: key regulators of T-cell development and function. Nat Rev Immunol 5:472-484.
24. Meade EA, McIntyre TM, Zimmerman GA, and Prescott SM (1999) Peroxisome proliferators enhance cyclooxygenase-2 expression in epithelial cells. J Biol Chem 274:8328-8334.
25. Mechoulam R, Ben-Shabat S, Hanus L, Ligumsky M, Kaminski NE, Schatz AR, Gopher A, Almog S, Martin BR, and Compton DR (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 50:83-90.
26. Nagy L, Tontonoz P, Alvarez JG, Chen H, and Evans RM (1998) Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell 93:229-240. (Pubitemid 28180856)
27. Ouyang Y, Hwang SG, Han SH, and Kaminski NE (1998) Suppression of interleukin-2 by the putative endogenous cannabinoid 2-arachidonyl-glycerol is mediated through down-regulation of the nuclear factor of activated T cells. Mol Pharmacol 53:676-683. (Pubitemid 28196490)
28. Piomelli D (2003) The molecular logic of endocannabinoid signalling. Nat Rev Neurosci 4:873-884.
29. Ricote M, Li AC, Willson TM, Kelly CJ, and Glass CK (1998) The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391:79-82. (Pubitemid 28079218)
30. Rockwell CE and Kaminski NE (2004) A cyclooxygenase metabolite of anandamide causes inhibition of interleukin-2 secretion in murine splenocytes. J Pharmacol Exp Ther 311:683-690. (Pubitemid 39391556)
31. Rockwell CE, Raman P, Kaplan BL, and Kaminski NE (2008) A COX-2 metabolite of the endogenous cannabinoid, 2-arachidonyl glycerol, mediates suppression of IL-2 secretion in activated Jurkat T cells. Biochem Pharmacol 76:353-361.
32. Rockwell CE, Snider NT, Thompson JT, Vanden Heuvel JP, and Kaminski NE (2006) Interleukin-2 suppression by 2-arachidonyl glycerol is mediated through peroxisome proliferator-activated receptor gamma independently of cannabinoid receptors 1 and 2. Mol Pharmacol 70:101-111.
33. Schmidt A, Endo N, Rutledge SJ, Vogel R, Shinar D, and Rodan GA (1992) Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids. Mol Endocrinol 6:1634-1641.
34. Stella N, Schweitzer P, and Piomelli D (1997) A second endogenous cannabinoid that modulates long-term potentiation. Nature 388:773-778. (Pubitemid 27375156)
35. Subbaramaiah K, Lin DT, Hart JC, and Dannenberg AJ (2001) Peroxisome proliferator-activated receptor gamma ligands suppress the transcriptional activation of cyclooxygenase-2. Evidence for involvement of activator protein-1 and CREB-binding protein/p300. J Biol Chem 276:12440-12448.
36. Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, Itoh K, Yamashita A, and Waku K (1995) 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun 215:89-97.
37. Sugiyama H, Nonaka T, Kishimoto T, Komoriya K, Tsuji K, and Nakahata T (2000) Peroxisome proliferator-activated receptors are expressed in human cultured mast cells: a possible role of these receptors in negative regulation of mast cell activation. Eur J Immunol 30:3363-3370. (Pubitemid 32005206)
38. Vanden Heuvel JP, Thompson JT, Frame SR, and Gillies PJ (2006) Differential activation of nuclear receptors by perfluorinated fatty acid analogs and natural fatty acids: a comparison of human, mouse, and rat peroxisome proliferator-activated receptor-alpha, -beta, and -gamma, liver X receptor-beta, and retinoid X receptor-alpha. Toxicol Sci 92:476-489. (Pubitemid 44018964)
39. Willson TM, Lehmann JM, and Kliewer SA (1996) Discovery of ligands for the nuclear peroxisome proliferator-activated receptors. Ann NY Acad Sci 804:276-283. (Pubitemid 27056616)
40. Yang XY, Wang LH, Chen T, Hodge DR, Resau JH, DaSilva L, and Farrar WL (2000) Activation of human T lymphocytes is inhibited by peroxisome proliferator-activated receptor gamma (PPARgamma) agonists. PPARgamma co-association with transcription factor NFAT. J Biol Chem 275:4541-4544. (Pubitemid 30108833)